APA (7th ed.) Citation

Zeyen, T., Potthoff, A., Nemeth, R., Heiland, D. H., Burger, M. C., Steinbach, J. P., . . . Güresir, E. (2022). Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial. Trials, 23(1), 1. https://doi.org/10.1186/s13063-021-05977-0

Chicago Style (17th ed.) Citation

Zeyen, Thomas, et al. "Phase I/II Trial of Meclofenamate in Progressive MGMT-methylated Glioblastoma Under Temozolomide Second-line Therapy—the MecMeth/NOA-24 Trial." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-021-05977-0.

MLA (9th ed.) Citation

Zeyen, Thomas, et al. "Phase I/II Trial of Meclofenamate in Progressive MGMT-methylated Glioblastoma Under Temozolomide Second-line Therapy—the MecMeth/NOA-24 Trial." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-021-05977-0.